Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693314 · ClinicalTrials.gov registry record · NA
Evaluation of Jarro-Dophilus EPS® Probiotic Formulations
A NA study of Healthy, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02693314 is a NA study of Healthy that has completed, run by University of Florida. The registered enrollment target is 75 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02693314, a NA study of Healthy, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of the two doses of Jarro-Dophilus EPS® probiotic supplements on fecal lactobacillus and bifidobacteria numbers, transit survival of administered probiotic strains, fecal microbiota, gastrointestinal function and general wellbeing in healthy human adults.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Jarro-Dophilus EPS® (5 billion CFU/capsule)
- DIETARY_SUPPLEMENT Jarro-Dophilus EPS® High Potency (25 billion CFU/capsule)
Study Locations (1)
Florida
- Food Science and Human Nutrition Department, University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02693314
The ClinicalTrials.gov registry entry for NCT02693314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02693314 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02693314 about?
NCT02693314 is a clinical study titled "Evaluation of Jarro-Dophilus EPS® Probiotic Formulations". The purpose of this study is to determine the effects of the two doses of Jarro-Dophilus EPS® probiotic supplements on fecal lactobacillus and bifidobacteria numbers, transit survival of administered probiotic strains, fecal microbiota, gastrointestinal function and general wellbeing in healthy huma...
What is the current status of trial NCT02693314?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2016-03. Estimated completion is 2016-04.
What conditions does trial NCT02693314 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02693314?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Jarro-Dophilus EPS® (5 billion CFU/capsule) (DIETARY_SUPPLEMENT), Jarro-Dophilus EPS® High Potency (25 billion CFU/capsule) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02693314?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02693314 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.